|
LRPPRC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.52739989731788E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.48279960427078E-10 |
| Normal-vs-Stage2 |
3.919200E-03 |
| Normal-vs-Stage3 |
4.02409999999964E-05 |
| Normal-vs-Stage4 |
8.741500E-02 |
| Stage1-vs-Stage2 |
2.899600E-01 |
| Stage1-vs-Stage3 |
4.615400E-01 |
| Stage1-vs-Stage4 |
1.978590E-01 |
| Stage2-vs-Stage3 |
7.065000E-01 |
| Stage2-vs-Stage4 |
6.791400E-01 |
| Stage3-vs-Stage4 |
4.316400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.89620011201453E-10 |
| Normal-vs-AfricanAmerican |
3.87169999949144E-07 |
| Normal-vs-Asian |
2.116200E-01 |
| Caucasian-vs-AfricanAmerican |
4.640000E-01 |
| Caucasian-vs-Asian |
5.997000E-01 |
| AfricanAmerican-vs-Asian |
7.790200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.50059964454385E-11 |
| Normal-vs-Female |
2.377200E-03 |
| Male-vs-Female |
1.438060E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.08950000005304E-06 |
| Normal-vs-Extreme_Weight |
4.54558612972278E-12 |
| Normal-vs-Obese |
1.30880000004385E-06 |
| Normal-vs-Extreme_Obese |
4.627800E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.228630E-01 |
| Normal_Weight-vs-Obese |
6.206400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.912200E-01 |
| Extreme_Weight-vs-Obese |
1.081800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.191650E-01 |
| Obese-vs-Extreme_Obese |
8.892600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.239400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.95189997077262E-09 |
| Normal-vs-Age(61-80Yrs) |
3.78470033091105E-10 |
| Normal-vs-Age(81-100Yrs) |
1.8166499999972E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.557720E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.434200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.344200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.792200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.221600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.185800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.93245419666255E-12 |
| Normal-VS-Type2 PRCC |
3.371900E-04 |
| Normal-VS-KIRP CIMP |
8.670200E-01 |
| Normal-VS-Unclassified PRCC |
2.237400E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.361100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.910100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.455570E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.297190E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.322200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.273700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.20590004648591E-09 |
| Normal-vs-N1 |
3.124100E-02 |
| Normal-vs-N2 |
3.104400E-01 |
| N0-vs-N1 |
1.780010E-02 |
| N0-vs-N2 |
1.040790E-01 |
| N1-vs-N2 |
7.335200E-01 |
|
|
